Calidi BiotherapeuticsCLDI
13F holders, Q1 2026 (March 31)28holders +1
5new positions
5sold out
$0.24avg. 13F price*
At the end of Q1 2026, 28 institutions reported holding Calidi Biotherapeutics Inc. (CLDI) in their 13F filings, up 1 from Q4 2025. 5 opened new positions and 5 sold out. The largest holders were Armistice Capital, LLC ($210K), Sabby Management, LLC ($104K) and Warberg Asset Management LLC ($59K).
- Company
- Calidi Biotherapeutics Inc.
- CUSIP
- 320703408
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $384K |
| Exits | 5 | $182K |
All 13F filers, Q4 2025 → Q1 2026: 1,738,390 shares bought and 178,833 shares sold, net +1,559,557 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 28 holders
| Armistice Capital, LLC | 0.01% | New | 879,000 | $210K |
| Sabby Management, LLC | 1.96% | New | 434,903 | $104K |
| Warberg Asset Management LLC | 0.12% | New | 250,000 | $59K |
| HighTower Advisors, LLC | 0.00% | No change | 83,523 | $20K |
| Virtu Financial LLC | 0.00% | Add +256.7% | 75,769 | $18K |
| Geode Capital Management, LLC | 0.00% | Add +50.3% | 63,019 | $15K |
| RS Crum Inc. | 0.00% | Add +98.7% | 40,256 | $10K |
| Arax Advisory Partners | 0.00% | New | 37,345 | $9K |
| Jane Street Group, LLC | 0.00% | Add +202.9% | 34,802 | $8K |
| Vanguard Capital Management LLC | 0.00% | — | 25,509 | $6K |
| Belpointe Asset Management LLC | 0.00% | Reduce -0.3% | 19,921 | $5K |
| Northern Trust Corp. | 0.00% | No change | 17,758 | $4K |
| Farther Finance Advisors, LLC | 0.00% | No change | 10,000 | $2K |
| Morgan Stanley | 0.00% | Add +545.3% | 9,467 | $2K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 9,219 | $2K |
| HRT Financial LP | 0.00% | New | 10,133 | $2K |
| Osaic Holdings, Inc. | 0.00% | No change | 2,106 | $503 |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -49.7% | 1,396 | $333 |
| Finepoint Capital LP | 0.00% | No change | 1,042 | $249 |
| Apollo Management Holdings, L.P. | 0.00% | No change | 1,042 | $249 |
| Highbridge Capital Management LLC | 0.00% | No change | 1,042 | $248 |
| FMR LLC | 0.00% | Reduce -98.8% | 255 | $61 |
| SBI Securities Co., Ltd. | 0.00% | Add +150.0% | 115 | $27 |
| Tradewinds Capital Management, LLC | 0.00% | No change | 101 | $25 |
| Reyes Financial Architecture, Inc. | 0.00% | No change | 100 | $24 |
| CVA Family Office, LLC | 0.00% | No change | 42 | $10 |
| Citigroup Inc. | 0.00% | Add +1300.0% | 14 | $3 |
| Evermay Wealth Management LLC | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is CLDI's weight in each manager's 13F, not the share of Calidi Biotherapeutics Inc. the manager owns.